UK Biobank and similar resources have made an extraordinary contribution to biomedical research, enabling important advances across genomics, population health, and disease understanding. Recent reports concerning data access have prompted important discussion across the research ecosystem – not about one institution alone, but about how participant trust is maintained as precision medicine becomes more data-intensive, distributed, and global.
These discussions reflect a wider shift in biomedical research. As datasets become larger, access networks more distributed, and research use cases more complex, governance needs to evolve alongside data science. The question is not only how data is protected, but how trust is designed into the full research lifecycle for the people who make precision medicine possible.
The foundation of large-scale genomic datasets is voluntary participation. Individuals contribute deeply personal information with an implicit expectation of stewardship and purpose.
Erosion of trust introduces several systemic risks:
Historically, de-identification has been a central mechanism for protecting participant privacy. Removing direct identifiers such as names and contact details has played an important role in enabling data sharing for research.
Advances in data science and the increasing availability of external datasets have made it possible, in some cases, to re-identify individuals. In this context, de-identification remains important, but it should sit within a broader trust model that includes consent, monitoring, accountability, and participant communication.
For researchers and sponsors, this means protection needs to be actively managed across the full lifecycle of data access and use.
Many data incidents in healthcare involve challenges in how data is accessed and handled after access is granted.
As research networks scale and datasets are accessed by global communities, governance models are evolving. These models have traditionally relied on:
There is a growing shift toward more controlled access environments, where:
As research becomes more distributed and data-intensive, access governance is evolving alongside advances in data science.
As precision medicine becomes more data-intensive and globally connected, expectations around how participant data is handled are becoming more explicit. Data stewardship is increasingly understood as a participant-centered responsibility that spans the entire research lifecycle.
Participants need clarity on why data is being collected, how it will be used, who can access it, and what safeguards are in place. Trust is established early and shapes long-term participation.
Access controls, auditability, consent management, and data-use transparency need to be designed into research programs from the beginning. These elements function as core infrastructure that supports both compliance and participant confidence.
Precision medicine depends on longitudinal data, recontact, and ongoing engagement. Maintaining clear communication with participants about how their data contributes to research helps support continued involvement.
From recruitment and genetic testing to engagement, recontact, analytics, and compliance, trust needs to be embedded across the entire research journey. Treating these as connected components rather than isolated steps supports more consistent and transparent participant experiences.
Precision medicine is entering a phase of rapid expansion. Data volumes are increasing, analytical capabilities are advancing, and collaboration is becoming more global.
Trust enables participation, supports research, and underpins the translation of scientific insights into clinical impact.
Maintaining that trust is a shared responsibility across researchers, institutions, technology providers, and regulators. It requires ongoing investment, clear communication, and adaptation as expectations evolve.
Patients and participants are far more than contributors to research; they are its foundation.
Ensuring that their data is handled with care, transparency, and respect is central to delivering on the promise of precision medicine.